CurrentRheuma
Get Weekly

Topic · page 16 of 40

Rheumatoid arthritis

Early and established rheumatoid arthritis in adults: diagnosis and prediction (clinically suspect arthralgia, people at risk), treat-to-target, conventional, biologic and targeted synthetic drugs, tapering and withdrawal, glucocorticoids, extra-articular disease and rheumatoid arthritis–associated interstitial lung disease

Briefs 601–640 of 1,564 placed here, newest publication first

Briefs in Rheumatoid arthritis

Newest publication first

  1. RMD Open

    Incidence of rheumatoid arthritis in Austria: a prospective population-based cohort study in a federal province

    Cohort study

  2. Semin Arthritis Rheum

    Classification criteria of joint activity using joint index vector for patients with rheumatoid arthritis: An evaluation and verification

    Diagnostic or prognostic study

  3. Semin Arthritis Rheum

    Quantifying and improving rheumatoid arthritis algorithm performance in biobank settings

    Cohort study

  4. Arthritis Res Ther

    Exploring the association between Mycobacterium avium subspecies paratuberculosis infection and rheumatoid arthritis: an immunological perspective

    Case-control study

  5. Ann Rheum Dis

    Mosaic loss of chromosome Y characterises late-onset rheumatoid arthritis and contrasting associations of polygenic risk score based on age at onset

    Case-control study

  6. Ann Rheum Dis

    Effectiveness and safety of the recombinant zoster vaccine in individuals ≥50 years of age with rheumatoid arthritis: a matched cohort and self-controlled case series study

    Cohort study

  7. Rheumatology (Oxford)

    Baseline synovitis–tenosynovitis is associated with remission in early rheumatoid arthritis, but discordance with disease activity is a changeable state

    Secondary analysis

  8. Ann Rheum Dis

    Do newly approved drugs have a worse observed safety profile than once established? A study on time trends in risks of key safety outcomes with immunomodulatory drugs against rheumatoid arthritis

    Cohort study

  9. Osteoporos Int

    Rheumatoid arthritis and subsequent fracture risk: an individual person meta-analysis to update FRAX

    Meta-analysis

  10. Ann Rheum Dis

    Predictors of arthritis development in individuals at risk of rheumatoid arthritis: a 5-year follow-up study from a large cohort

    Cohort study

  11. Arthritis Res Ther

    CXCL7 enhances RANKL-induced osteoclastogenesis via the activation of ERK/NFATc1 signaling pathway in inflammatory arthritis

    Mechanistic study

  12. Rheumatology (Oxford)

    Shorter reproductive time span and early menopause increase the risk of ACPA-negative inflammatory arthritis in postmenopausal women with clinically suspect arthralgia

    Cohort study

  13. Rheumatology (Oxford)

    Urological cancer risk in patients with rheumatoid arthritis compared to matched controls: a nationwide cohort study

    Cohort study

  14. Rheumatology (Oxford)

    Can treatment expectations or treatment itself in patients with arthralgia suspicious for progression to rheumatoid arthritis improve illness perceptions?

    Secondary analysis

  15. Rheumatology (Oxford)

    Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritis

    Cohort study

  16. Rheumatology (Oxford)

    Cancer risk of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs among older Americans with rheumatoid arthritis

    Case-control study

  17. Rheumatology (Oxford)

    Comparison of the efficacy and safety of methotrexate injection and methotrexate tablets in active RA

    Randomized controlled trial

  18. Rheumatology (Oxford)

    Anti-citrullinated procollagen C-endopeptidase enhancer antibody (anti-PCOLCE): a potential biomarker for seronegative rheumatoid arthritis

    Diagnostic or prognostic study

  19. Rheumatology (Oxford)

    Evaluation of patient-based disease activity score (PDAS) in the Japanese rheumatoid arthritis patient registry (NinJa registry)

    Cross-sectional study

  20. Lancet Rheumatol

    Survival in patients with rheumatoid arthritis and recently diagnosed early-stage colorectal, lung, or prostate cancer receiving tumour necrosis factor inhibitors: a retrospective cohort study

    Cohort study

  21. Arthritis Res Ther

    Long-term outcome of a treat-to-target strategy in late-onset rheumatoid arthritis with chronic lung disease: 5-year results of a prospective observational study

    Cohort study

  22. Arthritis Rheumatol

    Associations of Fire Smoke and Other Pollutants With Incident Rheumatoid Arthritis and Rheumatoid Arthritis–Associated Interstitial Lung Disease

    Case-control study

  23. J Rheumatol

    Unacceptable Work State in Rheumatoid Arthritis: Establishment of Thresholds for Presenteeism and Clinical Measurement Instruments

    Diagnostic or prognostic study

  24. Arthritis Res Ther

    Predicting abatacept retention using machine learning

    Secondary analysis

  25. RMD Open

    Porphyromonas gingivalis associates with the presence of anti-citrullinated protein antibodies, but not with the onset of arthritis: studies in an at-risk population

    Cohort study

  26. RMD Open

    Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study

    Randomized controlled trial

  27. Arthritis Res Ther

    Diagnostic performance of optical spectral transmission compared to magnetic resonance imaging in patients with inflammatory arthritis

    Diagnostic or prognostic study

  28. Semin Arthritis Rheum

    Tender joints in early autoantibody-negative rheumatoid arthritis: Should they be included in the scoring of joint involvement of the 2010 ACR/EULAR classification criteria?

    Cohort study

  29. Semin Arthritis Rheum

    Mortality and medical utilization in rheumatoid arthritis associated interstitial lung disease: A real-world, large-scale retrospective study comparing Janus kinase inhibitors and tumor necrosis factor inhibitors

    Cohort study

  30. RMD Open

    Prediction of long-term drug-free outcomes in ACPA-positive and ACPA-negative rheumatoid arthritis by combined clinical and ultrasound assessment of residual disease: a 5-year prospective study

    Cohort study

  31. RMD Open

    Work loss in patients with rheumatoid arthritis treated with abatacept, rituximab, tocilizumab or TNF inhibitors: a nationwide direct drug-to-drug comparison

    Cohort study

  32. Rheumatology (Oxford)

    A predictive model based on the gut microbiota improves the diagnostic effect in patients with rheumatoid arthritis

    Diagnostic or prognostic study

  33. Semin Arthritis Rheum

    Age of onset of rheumatoid arthritis and radiographic changes

    Cohort study

  34. Arthritis Rheumatol

    Endogenous Retroelement Activation is Implicated in Interferon‐α Production and Anti–Cyclic Citrullinated Peptide Autoantibody Generation in Early Rheumatoid Arthritis

    Mechanistic study

  35. Rheumatology (Oxford)

    Imaging tests as predictors of progression to rheumatoid arthritis in clinically suspect arthralgia: a systematic review and meta-analysis

    Meta-analysis

  36. Rheumatology (Oxford)

    Efficacy and safety of first-line targeted synthetic DMARDs in rheumatoid arthritis patients with chronic kidney disease

    Cohort study

  37. RMD Open

    Distinct clinical outcomes based on multiple serum cytokine and chemokine profiles rather than autoantibody profiles and ultrasound findings in rheumatoid arthritis: a prospective ultrasound cohort study

    Cohort study

  38. RMD Open

    Persistently different patterns of patient’s global assessment of health in rheumatoid arthritis are associated with pain and impaired function more than with inflammation: an inception cohort study over 15 years

    Cohort study

  39. RMD Open

    Switching to biological DMARDs versus cycling among JAK inhibitors in patients with rheumatoid arthritis and with inadequate response to JAK inhibitors: from FIRST registry

    Cohort study

  40. Rheumatology (Oxford)

    Circulating secretory component-containing anti-citrullinated protein antibodies prior to symptom onset in rheumatoid arthritis

    Case-control study

All 1,564 Briefs in ExploreShowing Briefs 601–640 of 1,564, newest first